Skip to content
Agentmart
Submit a tool

dyslipidemia-ldl-treatment-goals-2026

Set absolute LDL-C, non-HDL-C, and ApoB treatment goals, PLUS percent LDL-C reduction, for a primary-prevention patient on lipid-lowering therapy per the…

Skill by dromlakhani

IndexedLicense unknown★ 14
Write a review

Chalk Labs

Need help deploying dyslipidemia-ldl-treatment-goals-2026?

Chalk Labs sets up agents like this inside real teams: connected to your tools, tested on your data, with a human in the loop where it matters.

Book a call

Install

Works with Claude Code, Claude apps, Codex, Cursor, Gemini CLI, GitHub Copilot, VS Code, OpenCode, Goose, Windsurf. Read the repository before you give any tool access to your data.

npx agentmarket install skill/dromlakhani-dyslipidemia-ldl-treatment-goals-2026

Asks which of your tools to add it to (Claude Code, Codex, Cursor, VS Code, Windsurf, Gemini CLI, Claude Desktop) and shows the change first. See https://agentmart.dev/cli.

Get the weekly diff

The weekly diff: one email a week with new agent tools, notable updates and grade changes, plus security alerts for tools you follow. Double opt-in, one-click unsubscribe.

We use your email only for this newsletter. Privacy

About

Set absolute LDL-C, non-HDL-C, and ApoB treatment goals, PLUS percent LDL-C reduction, for a primary-prevention patient on lipid-lowering therapy per the re-introduced treatment goals in the 2026 ACC/AHA multisociety dyslipidaemia guideline. Covers goals by PREVENT-ASCVD category (low / borderline / intermediate / high), by CAC score, in severe hypercholesterolaemia / FH, in diabetes with multiple ASCVD risk factors, and the ApoB targets once LDL-C and non-HDL-C goals are met. Use when a clinician asks what LDL goal to aim for, LDL target for intermediate risk, non-HDL goal, ApoB target, dual goals on statin, patient at goal or not, how low should LDL go, statin not enough what next. Grounded in the 2026 ACC/AHA multisociety dyslipidaemia guideline.

No reviews yet. Installed it? Reviews come from verified installers only. How reviews work

Permissions

What this skill can do and what it asks for, from its SKILL.md and code. Checked Oct 25, 2026.

Tools
No tools found
Secrets
None asked for
Install scripts
None found

Network hosts it talks to 1

  • codeload.github.com · found in install command

Files it touches

  • ~/.claude/skills/dyslipidemia-ldl-treatment-goals-2026

What's inside

Skill name
dyslipidemia-ldl-treatment-goals-2026
Description
Set absolute LDL-C, non-HDL-C, and ApoB treatment goals, PLUS percent LDL-C reduction, for a primary-prevention patient on lipid-lowering therapy per the re-introduced treatment goals in the 2026 ACC/AHA multisociety dyslipidaemia guideline. Covers goals by PREVENT-ASCVD category (low / borderline / intermediate / high), by CAC score, in severe hypercholesterolaemia / FH, in diabetes with multiple ASCVD risk factors, and the ApoB targets once LDL-C and non-HDL-C goals are met. Use when a clinician asks what LDL goal to aim for, LDL target for intermediate risk, non-HDL goal, ApoB target, dual goals on statin, patient at goal or not, how low should LDL go, statin not enough what next. Grounded in the 2026 ACC/AHA multisociety dyslipidaemia guideline.
License
unknown
Instructions
133 lines in SKILL.md · view on GitHub

Files (1)

  • SKILL.md

The license isn't open source, so the instructions aren't shown here. Read SKILL.md on GitHub

More from dromlakhani/MD2SKILL

Signals

Stars
14
Forks
1
Open issues
1
Last commit (this folder)
Oct 5, 2026 (26 days ago)

From GitHub (fetched Oct 24, 2026).

Details

License
License unknown
First seen
Oct 24, 2026
Last checked
Oct 24, 2026

More from dromlakhani

Done for you

Rather not set it up yourself?

Chalk Labs scopes, builds and runs agents for your team: the task audit, the eval harness, the integrations and the weekly ops report. Fixed scope, priced before we start.

See how we build AI agents →Read the case studies

Chalk Labs is a two-founder AI and growth studio. We build AI agents, CRMs and MVPs for Web3 and AI companies, and have shipped 50+ product and token launches.

launches shipped
50+
launches shipped
media placements
500+
media placements
founders on every account
2
founders on every account

Press we've placed: Forbes · CoinDesk · Decrypt · Cointelegraph · The Block

Rahil Jain, Co-founder, Chalk Labs. Ex-Goldman Sachs engineer. You talk to the person who builds it.

Get dyslipidemia-ldl-treatment-goals-2026 running in your business

Tell us what you want to automate. A founder replies within one working day with a plan, not a pitch deck.

Goes to the Chalk Labs founders, not the newsletter. Privacy

Need help deploying dyslipidemia-ldl-treatment-goals-2026?

CallGet help
Cite this page

dyslipidemia-ldl-treatment-goals-2026 skill. Agent Mart. https://agentmart.dev/skills/dromlakhani-dyslipidemia-ldl-treatment-goals-2026 (last updated 2026-10-24)